The global wound care biologics market was worth US$ 1.4 Billion in 2018. Looking forward, the market is projected to reach a value of US$ 2.35 Billion by 2024, registering a CAGR of around 9% during 2019-2024.
Some of the recent technological advancements made in the field of wound healing include skin substitutes, bio-membranes, scaffolds, hydroconductive dressings and biologics.
Chronic skin wounds can be caused due to burns, skin cancers, infections, trauma or an underlying medical condition such as diabetes. With the growing prevalence of these ailments along with the expanding geriatric population, there has been a rise in the demand for treatments that can accelerate wound healing and facilitate a speedy recovery. Along with this, several initiatives have been undertaken by governments across the globe to create awareness about the benefits of wound care biologics among patients.
Apart from this, manufacturers are also developing next-generation, cost-effective and high-quality biologics to make them more accessible. Moreover, many research and healthcare centers are entering into partnerships to modernize wound care treatments and develop innovative drugs for healing wounds. For example, researchers are focusing on integrating antimicrobial compounds into the wound dressing itself. These materials combine traditional wound dressings such as hydrogels or foams with antimicrobial compounds such as betaine, silver, chitin, or polyhexamethylene biguanide.
Key Questions Answered
How has the global wound care biologics market performed so far and how will it perform in the coming years?
What are the key regional markets in the global wound care biologics industry?
What is the breakup of the market based on the product?
What is the breakup of the market based on the wound type?
What is the breakup of the market based on the application?
What is the breakup of the market based on the end-user?
What are the various stages in the value chain of the global wound care biologics industry?
What are the key driving factors and challenges in the global wound care biologics industry?
What is the structure of the global wound care biologics industry and who are the key players?
What is the degree of competition in the global wound care biologics industry?
Key Topics Covered
2 Scope and Methodology
3 Executive Summary
4 Introduction 4.1 Overview 4.2 Key Industry Trends
5 Global Wound Care Biologics Market 5.1 Market Overview 5.2 Market Performance 5.3 Market Breakup by Product 5.4 Market Breakup by Wound Type 5.5 Market Breakup by Application 5.6 Market Breakup by End-user 5.7 Market Breakup by Region 5.8 Market Forecast
13 Porter's Five Forces Analysis 13.1 Overview 13.2 Bargaining Power of Buyers 13.3 Bargaining Power of Suppliers 13.4 Degree of Competition 13.5 Threat of New Entrants 13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape 15.1 Market Structure 15.2 Key Players 15.3 Profiles of Key Players 15.3.1 Smith & Nephew 15.3.2 Mlnlycke Health Care 15.3.3 Integra lifesciences 15.3.4 Osiris Therapeutics 15.3.5 Avita Medical 15.3.6 ConvaTec Group 15.3.7 Cytori Therapeutics 15.3.8 Mylan 15.3.9 Johnson & Johnson 15.3.10 Leap Therapeutics 15.3.11 Nuo Therapeutics 15.3.12Mallinckrodt 15.3.13 Wright Medical 15.3.14 Mimedx Group 15.3.15 Solsys Medical